Call Now! 866-464-3202
This is a custom template (Home Pages: Video Center Area - AUTO PLAY WITH MUTED SOUND) that is currently displayed on the following pages: * third column

Video Center

Halozyme Therapeutics, Inc. · San Diego, CA United States ·(NASDAQ (GM): HALO)

Company Description

11388 Sorrento Valley Rd.
San Diego, CA
92121
United States (Map)
Phone: 858-794-8889
Fax: 858-704-8311
    View Halozyme Therapeutics, Inc. Locations On A US MapThis link will open in a new window

    Halozyme Therapeutics makes enzymes for therapeutic and drug delivery applications. The company's products are based on recombinant human PH20, a human synthetic enzyme it hopes will offer safety benefits over animal-derived versions. The firm's first commercial product, Cumulase, is used for in-vitro fertilization. Another product, Hylenex, is used as an adjuvant for drug and fluid infusions. Products under development include drug delivery agents using the company's Enhanze technology, as well as therapeutic enzymes for cancer, metabolism, and dermatology applications. Halozyme's development partners include Roche and Baxter InternationalTo read the full description, subscribe now.

    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!

    Key Halozyme Therapeutics, Inc. Financials

    Company TypePublic - NASDAQ (GM): HALO

    Headquarters
    Fiscal Year-EndDecember
    2008 Sales (mil.)$8.8
    2008 Employees129

    Halozyme Therapeutics, Inc. Executives

    22 executives listed for Halozyme Therapeutics, Inc.'s San Diego, CA location.
    TitleName & BioContact
    ChairmanKenneth KelleyNetwork
    President, CEO, and DirectorJonathan LimNetwork
    VP Manufacturing and OperationsWilliam FallonNetwork

    Competition

    Competitive Landscape for Halozyme Therapeutics, Inc.
    Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.
    Top Halozyme Therapeutics, Inc. Competitors
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!